{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:43:30Z","timestamp":1792755810437,"version":"4.5.0"},"reference-count":52,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T00:00:00Z","timestamp":1286150400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p>Chronic migraine (CM) is a prevalent and disabling neurological disorder. Few prophylactic treatments for CM have been investigated. OnabotulinumtoxinA, which inhibits the release of nociceptive mediators, such as glutamate, substance P, and calcitonin gene\u2010related peptide, has been evaluated in randomized, placebo\u2010controlled studies for the preventive treatment of a variety of headache disorders, including CM. These studies have yielded insight into appropriate patient selection, injection sites, dosages, and technique. Initial approaches used a set of fixed sites for the pericranial injections. However, the treatment approach evolved to include other sites that corresponded to the location of pain and tenderness in the individual patient in addition to the fixed sites. The Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) injection paradigm uses both fixed and follow\u2010the\u2010pain sites, with additional specific follow\u2010the\u2010pain sites considered depending on individual symptoms. The PREEMPT paradigm for injecting onabotulinumtoxinA has been shown to be safe, well\u2010tolerated, and effective in well\u2010designed, controlled clinical trials and is the evidence\u2010based approach recommended to optimize clinical outcomes for patients with CM.<\/jats:p>","DOI":"10.1111\/j.1526-4610.2010.01766.x","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T12:21:19Z","timestamp":1286194879000},"page":"1406-1418","source":"Crossref","is-referenced-by-count":216,"title":["Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well\u2010Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program"],"prefix":"10.1111","volume":"50","author":[{"given":"Andrew","family":"Blumenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Silberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena K.","family":"Aurora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Turkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,4]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000323925.29520.e7"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01941.x"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2006.01172.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200006000-00008"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-001-0070-6"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00691.x"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05066.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00963.x"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00066.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e31816f2cdd"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01652.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0948"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870020402"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(00)00146-9"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.1999.tb00044.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjom.1999.0238"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)90048-5"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.10.1290"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21427"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2006.00168.x"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2006.03.002"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01315.x"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.4065\/80.9.1126"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00624.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2006.01114.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01678.x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410364676"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410364677"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2005.01.017"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.43.7s.3.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2003.10.008"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04007.x"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00260-4"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-0101(99)00153-1"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.04.014"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.10.005"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhn.2000.110960"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05068.x"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01555.x"},{"key":"e_1_2_8_42_2","unstructured":"Committee for Medicinal Products for Human Use.Guideline on clinical investigation of medicinal products for the treatment of migraine.http:\/\/www.emea.europa.eu\/pdfs\/human\/ewp\/078801enfin.pdf. Accessed June 7 2010."},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1991.1101001.x"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00621.x"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.6.8.1147"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00851.x"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2008.01042.x"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00494.x"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00033.x"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.01.016"},{"key":"e_1_2_8_51_2","volume-title":"BOTOX\u00ae (Botulinum Toxin Type A) Full Prescribing Information","year":"2006"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2003.03167.x"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2007.2114"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2010.01766.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2010.01766.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:46:56Z","timestamp":1762076816000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2010.01766.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1526-4610.2010.01766.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01766.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}